US 9994613
Prodrug of an ICE inhibitor
granted A61KA61K38/00A61P
Quick answer
US patent 9994613 (Prodrug of an ICE inhibitor) held by Vertex Pharmaceuticals Incorporated expires Mon Jun 07 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Jun 12 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 07 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 27
- CPC classes
- A61K, A61K38/00, A61P, A61P1/00, A61P1/02